{"id":21219,"date":"2022-12-06T13:56:24","date_gmt":"2022-12-06T13:56:24","guid":{"rendered":"https:\/\/www.nottinghamtechventures.com\/?post_type=companies&p=21219"},"modified":"2022-12-21T16:11:16","modified_gmt":"2022-12-21T16:11:16","slug":"isomab","status":"publish","type":"companies","link":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","title":{"rendered":"IsomAb"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"
IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.<\/p>\n","protected":false},"featured_media":21234,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"sector":[150],"spin_out_name":[195],"acf":[],"yoast_head":"\n